Lung Cancer

David Carbone, MD, PhD, received International Association for the Study of Lung Cancer’s Paul A. Bunn Jr. Scientific Award.

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer.

An expert panel has developed recommendations on best practices for managing clinically relevant immune-related adverse events associated with immune checkpoint inhibitor treatment.

Exposure to the colorless, odorless gas called radon is the second leading cause of lung cancer in the U.S. and the leading cause of lung cancer among nonsmokers, according to the American Cancer Society.

In this vide, David R. Gandara, MD, spoke with Healio about the molecular tumor board discussion at the International Lung Cancer Congress.

In this video, Hossein Borghaei, DO, MS, discussed the impact of the pandemic on the care of patients with lung cancer, noting that at this year’s International Lung Cancer Congress, most conversations about COVID-19 took place off the podium.

Hossein Borghaei, DO, MS, spoke with Healio about his important takeaways from the International Lung Cancer Congress.

David R. Gandara, MD, summarized a crossfire panel from the International Lung Cancer Congress where experts discussed use of immunotherapy-containing regimens in the frontline setting for patients with advanced-stage non-small cell lung cancer.

In this video, David R. Gandara, MD, spoke with Healio about discussions surrounding the ADAURA trial held at the 22nd annual International Lung Cancer Congress.

In this video, Hossein Borghaei, DO, MS, told Healio that the presentations from this year’s International Lung Cancer Congress were “really good.”